Matches in Nanopublications for { ?s ?p "[Both plasma and CSF in patients with relapsing/remitting MS and marked gadolinium enhancement contained the two major molecular species of PAF: 1-0-hexadecyl- (C16:O) and 1-0-octadecyl-sn-glycero-3-phosphocholine (C18:O).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_assertion description "[Both plasma and CSF in patients with relapsing/remitting MS and marked gadolinium enhancement contained the two major molecular species of PAF: 1-0-hexadecyl- (C16:O) and 1-0-octadecyl-sn-glycero-3-phosphocholine (C18:O).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_provenance.
- NP651655.RA3hwmGFxOEo01rTMdF24XXzxP-amqf7oWq0HogjNv0yg130_assertion description "[Both plasma and CSF in patients with relapsing/remitting MS and marked gadolinium enhancement contained the two major molecular species of PAF: 1-0-hexadecyl- (C16:O) and 1-0-octadecyl-sn-glycero-3-phosphocholine (C18:O).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651655.RA3hwmGFxOEo01rTMdF24XXzxP-amqf7oWq0HogjNv0yg130_provenance.